financetom
Market
financetom
/
Market
/
What's Going On With Carvana Stock Wednesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Carvana Stock Wednesday?
Sep 11, 2024 12:12 PM

Carvana Co ( CVNA ) shares are trading lower by 1.4% to $128.96 Wednesday afternoon, though off the session low of $126.59. The stock fell following the release of the U.S. Consumer Price Index (CPI) inflation report for August, which revealed a persistent rise in core inflation, despite the headline inflation rate easing to its lowest level since February 2021.

The stock dropped early Wednesday as investors reacted to a surge in Treasury yields, driven by concerns over the potential for prolonged higher interest rates.

Inflation Data and Market Reaction

Inflation Data and Market Reaction: According to the report, headline CPI inflation fell to 2.5% in August, down from 2.9% in July, below the expected 2.6%. However, core inflation, which excludes food and energy prices, increased by 0.3% on a month-over-month basis, surpassing expectations of 0.2%.

The rise in core inflation points to continued pricing pressures in critical areas such as shelter, education and motor vehicle insurance, signaling that the Federal Reserve may hold off on interest rate cuts.

Read Also: What’s Going On With First Solar Stock?

Impact on Carvana's Business

Impact on Carvana’s Business: Carvana ( CVNA ), an online used car retailer, is highly sensitive to shifts in both consumer purchasing power and borrowing costs. The unexpected rise in core inflation suggests that the cost of living for U.S. consumers is not easing as quickly as anticipated, which could hurt demand for big-ticket items like used cars.

Carvana's ( CVNA ) business model, which relies heavily on customers financing their vehicle purchases, may face additional pressure as rising interest rates increase the cost of auto loans, further dampening consumer demand.

Additionally, Carvana ( CVNA ) has significant debt on its balance sheet, making it particularly vulnerable to higher borrowing costs. With rising Treasury yields, the cost of servicing its debt could increase, potentially impacting the company’s profitability and cash flow. Investors appear to be pricing in these risks, leading to a decline in Carvana’s stock.

Read Also: Why Applied DNA Sciences Stock Is Skyrocketing

How To Buy CVNA Stock

By now you're likely curious about how to participate in the market for Carvana ( CVNA ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

In the case of Carvana ( CVNA ), which is trading at $129.25 as of publishing time, $100 would buy you 0.77 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

According to data from Benzinga Pro, CVNA has a 52-week high of $159.85 and a 52-week low of $25.09.

Read Next:

Bill Ackman And Elon Musk Blast Kamala Harris For Her Social Media Posts During Debate With Trump: ‘Even Her Tweets Are Not Her Own’

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US STOCKS-Megacaps boost futures as Wall Street stays upbeat ahead of data, earnings
US STOCKS-Megacaps boost futures as Wall Street stays upbeat ahead of data, earnings
Jul 10, 2024
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Powell due to speak at 10 a.m. ET * TSMC up on strong Q2 revenue growth * Illumina ( ILMN ) rises after acquiring Fluent BioSciences * Goodyear Tire up after report Yokohama's plans to buy unit * Futures:...
US Futures Nudge Higher as Jerome Powell Set to Testify Again Before Congress
US Futures Nudge Higher as Jerome Powell Set to Testify Again Before Congress
Jul 10, 2024
08:17 AM EDT, 07/10/2024 (MT Newswires) -- US stock futures were trending marginally higher in Wednesday's premarket activity ahead of Federal Reserve Chair Jerome Powell's Congressional testimony before the House Financial Services Committee. In his second day of testimony, Powell will provide a prepared statement followed by a question-and-answer session with the Committee. The Dow Jones Industrial Average futures were...
Sector Update: Tech
Sector Update: Tech
Jul 10, 2024
08:48 AM EDT, 07/10/2024 (MT Newswires) -- Technology stocks were mixed premarket Wednesday with the Technology Select Sector SPDR Fund (XLK) up 0.7% and the SPDR S&P Semiconductor ETF (XSD) declining by 1.6% recently. Taiwan Semiconductor Manufacturing Company ( TSM ) was up more than 2% after reporting June revenue of 207.87 billion New Taiwanese dollars ($6.37 billion), up from...
Sector Update: Health Care
Sector Update: Health Care
Jul 10, 2024
08:54 AM EDT, 07/10/2024 (MT Newswires) -- Health care stocks were steady premarket Wednesday as the Health Care Select Sector SPDR Fund (XLV) was up 0.03% and iShares Biotechnology ETF (IBB) was recently inactive. Illumina ( ILMN ) rose nearly 4% after saying it has acquired Fluent BioSciences, a privately held developer of a highly differentiated single-cell analysis technology. ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved